Buscar
01/04/2024
Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
Mauricio, D, Escalada, J, Pérez, A, Romero-Gómez, M, Cusi, K, Younoussi, ZM, Lazarus, JV. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists. Endocrinologia Diabetes y Nutricion. 2024; 71(4)DOI:10.1016/j.endien.2024.01.007. PMID:38735676. IF:1.800(Q3/8D).
29/03/2024
Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus
Barranco-Altirriba, M, Alonso, N, Weber, RJM, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Jankevics, A, Winder, C, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02202-5. PMID:38553758. IF:10.600(Q1/1D).
18/03/2024
Modulatory actions of Echinococcus granulosus antigen B on macrophage inflammatory activation
Folle, AM, Magallanes, SL, Fló, M, Alvez-Rosado, R, Carrión, F, Vallejo, C, Watson, D, Julve, J, González-Sapienza, G, Pristch, O, González-Techera, A, Ferreira, AM. Modulatory actions of Echinococcus granulosus antigen B on macrophage inflammatory activation. Frontiers in Cellular and Infection Microbiology. 2024; 14DOI:10.3389/fcimb.2024.1362765. PMID:38562963. IF:4.800(Q1/2D).
07/03/2024
Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles
Monroy, G, Fernández, C, Altimira, L, Barba, U, Corcoy, R. Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles. DIABETIC MEDICINE. 2024; 41(6)DOI:10.1111/dme.15315. PMID:38451734. IF:3.400(Q2/4D).
01/03/2024
Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics
Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2024; 23(1)DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2.500(Q3/7D).
01/03/2024
Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study
Vlacho, B, Fernandez-Camins, B, Canudas-Ventura, A, Rodríguez, A, Mollo, A, Claramunt, FXC, Antentas, M, Mauricio, D, Franch-Nadal, J. Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study. Journal of Clinical Medicine. 2024; 13(6)DOI:10.3390/jcm13061544. PMID:38541770. IF:2.900(Q1/2D).
08/02/2024
Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia
Ramírez-Morros, A, Franch-Nadal, J, Real, J, Miró-Catalina, Q, Bundó, M, Vlacho, B, Mauricio, D. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1339879. PMID:38390201. IF:4.600(Q1/3D).
01/02/2024
The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia
Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2024; 581DOI:10.1016/j.mce.2023.112113. PMID:37989409. IF:3.600(Q2/4D).
01/02/2024
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).
15/01/2024
The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review
Sloan, L, Cheng, AYY, Escalada, J, Haluzík, M, Mauricio, D. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review. DIABETES OBESITY & METABOLISM. 2024; 26(4)DOI:10.1111/dom.15425. PMID:38225217. IF:5.700(Q1/2D).
01/01/2024
Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.
Rotllan N, Julve J, Escolà-Gil JC. Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.. CURRENT MEDICINAL CHEMISTRY. 2024; 31(3)DOI:10.2174/0929867330666230201124125. PMID:36722477. IF:3.500(Q2/4D).
01/01/2024
The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
Chico A., Moreno-Fernández J., Fernández-García D., Solá E.. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2024; 15(1)DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2.600(Q3/6D).
01/01/2024
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
Rodríguez-Agudo, R, González-Recio, I, Serrano-Maciá, M, Bravo, M, Petrov, P, Blaya, D, Herranz, JM, Mercado-Gómez, M, Rejano-Gordillo, CM, Lachiondo-Ortega, S, Gil-Pitarch, C, Azkargorta, M, Van Liempd, SM, Martinez-Cruz, LA, Simao, AL, Elortza, F, Martín, C, Nevzorova, YA, Cubero, FJ, Delgado, TC, Argemi, J, Bataller, R, Schoonjans, K, Banales, JM, Castro, RE, Sancho-Bru, P, Avila, MA, Julve, J, Jover, R, Mabe, J, Simon, J, Goikoetxea-Usandizaga, N, Martínez-Chantar, ML. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. Jhep Reports. 2024; 6(1)DOI:10.1016/j.jhepr.2023.100918. PMID:38192540. IF:7.500(Q1/2D).
01/01/2024
Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019
Soldevila B., Alarcón L., Vlacho B., Real J., Hernández M., Cos X., Franch-Nadal J., Mauricio D.. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019. Primary Care Diabetes. 2024; 18(2)DOI:10.1016/j.pcd.2023.12.007. PMID:38228411. IF:2.300(Q2/5D).
01/01/2024
Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study
Gómez-Peralta, F, Valledor, X, López-Picado, A, Abreu, C, Fernández-Rubio, E, Cotovad, L, Pujante, P, García-Fernández, E, Azriel, S, Corcoy, R, Pérez-González, J, Ruiz-Valdepeñas, L. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study. Diabetes Technology & Therapeutics. 2024; 26(1)DOI:10.1089/dia.2023.0321. PMID:37902762. IF:6.300(Q1/2D).
01/01/2024
Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study
Ramírez-Morros, A, Berenguera, A, Millaruelo, L, Buil-Cosiales, P, Garcia, CG, Cos, X, Lachica, LA, Artola, S, Millaruelo, JM, Mauricio, D, Franch-Nadal, J. Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study. Patient Preference and Adherence. 2024; 18DOI:10.2147/PPA.S466931. PMID:39290823. IF:2.000(Q2/4D).
01/01/2024
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study
Durán-Martínez, M, Azriel, S, Doulatram-Gamgaram, VK, Moreno-Pérez, O, Pines-Corrales, PJ, Tejera-Pérez, C, Merino-Torres, JF, Brito-Sanfiel, M, Chico, A, Marco, A, García-Fernández, E, Martínez-Montoro, JI. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study. DIABETES & METABOLISM. 2024; 50(1)DOI:10.1016/j.diabet.2023.101501. PMID:38061425. IF:4.700(Q1/3D).
01/12/2023
Is the Spanish type 1 diabetes mellitus registry really necessary?
Escalada J., Pérez A., Rica I.. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10)DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1.800(Q3/8D).
01/12/2023
Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects
López-Yerena, A, Padro, T, Villaplana, VD, Muñoz-García, N, Pérez, A, Vilahur, G, Badimon, L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24)DOI:10.3390/nu15245084. PMID:38140343. IF:4.800(Q1/2D).
01/12/2023
Pharmacological modulation of vascular ageing: A review from VascAgeNet
Roth, L, Dogan, S, Tuna, BG, Aranyi, T, Benitez, S, Borrell-Pages, M, Bozaykut, P, De Meyer, GRY, Duca, L, Durmus, N, Fonseca, D, Fraenkel, E, Gillery, P, Giudici, A, Jaisson, S, Johansson, M, Julve, J, Lucas-Herald, AK, Martinet, W, Maurice, P, McDonnell, BJ, Ozbek, EN, Pucci, G, Pugh, CJA, Rochfort, KD, Roks, AJM, Rotllan, N, Shadiow, J, Sohrabi, Y, Spronck, B, Szeri, F, Terentes-Printzios, D, Aydin, ET, Tura-Ceide, O, Ucar, E, Yetik-Anacak, G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12.500(Q1/1D).